CME GROUP INC (CME) Forecast, Price Target & Analyst Ratings

NASDAQ:CME • US12572Q1058

Current stock price

285.06 USD
-0.41 (-0.14%)
At close:
285.06 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CME GROUP INC (CME).

Forecast Snapshot

Consensus Price Target

Price Target
$319.66
+ 12.14% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Jul 21, 2026
Period
Q2 / 2026
EPS Estimate
$3.14
Revenue Estimate
1.79B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
69.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$319.66
Upside
+ 12.14%
From current price of $285.06 to mean target of $319.66, Based on 20 analyst forecasts
Low
$243.41
Median
$326.40
High
$366.45

Price Target Revisions

1 Month
3.74%
3 Months
8.98%

Price Target Summary

20 Wall Street analysts provided a forecast for the next 12 months for CME. The average price target is 319.66 USD. This implies a price increase of 12.14% is expected in the next year compared to the current price of 285.06.
The average price target has been revised upward by 8.98% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CME Current Analyst RatingCME Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

CME Historical Analyst RatingsCME Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
69.00%
CME was analyzed by 20 analysts. The buy percentage consensus is at 69. So analysts seem to be have mildly positive about CME.
In the previous month the buy percentage consensus was at a similar level.
CME was analyzed by 20 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-23BarclaysMaintains Equal-Weight -> Equal-Weight
2026-04-23Morgan StanleyMaintains Overweight -> Overweight
2026-04-15Piper SandlerMaintains Overweight -> Overweight
2026-04-13BarclaysMaintains Equal-Weight -> Equal-Weight
2026-04-10Morgan StanleyMaintains Overweight -> Overweight
2026-04-08Keefe, Bruyette & WoodsReiterate Market Perform -> Market Perform
2026-04-08BarclaysMaintains Equal-Weight -> Equal-Weight
2026-03-04Argus ResearchDowngrade Buy -> Hold
2026-02-05TD CowenMaintains Buy -> Buy
2026-02-05RBC CapitalMaintains Sector Perform -> Sector Perform
2026-02-05BarclaysMaintains Equal-Weight -> Equal-Weight
2026-02-05JP MorganMaintains Underweight -> Underweight
2026-02-05Morgan StanleyMaintains Overweight -> Overweight
2026-01-15Morgan StanleyMaintains Overweight -> Overweight
2026-01-14TD CowenUpgrade Hold -> Buy
2025-12-22Morgan StanleyMaintains Overweight -> Overweight
2025-12-12BarclaysMaintains Equal-Weight -> Equal-Weight
2025-11-13Piper SandlerMaintains Overweight -> Overweight
2025-10-23UBSMaintains Neutral -> Neutral
2025-10-23Deutsche BankUpgrade Hold -> Buy
2025-10-23Morgan StanleyMaintains Overweight -> Overweight
2025-10-13Raymond JamesMaintains Outperform -> Outperform
2025-10-08BarclaysMaintains Equal-Weight -> Equal-Weight
2025-10-01Morgan StanleyMaintains Overweight -> Overweight
2025-09-25JP MorganMaintains Underweight -> Underweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Jul 21, 2026
Period
Q2 / 2026
EPS Estimate
$3.14
Revenue Estimate
1.79B
Revenue Q2Q
5.79%
EPS Q2Q
6.19%
Number of Analysts
15

Next Earnings Revisions

Revenue (1 Month)
6.47%
Revenue (3 Months)
9.78%
EPS (1 Month)
6.92%
EPS (3 Months)
12.41%

Next Earnings Summary

CME is expected to report earnings on 7/21/2026. The consensus EPS estimate for the next earnings is 3.14 USD and the consensus revenue estimate is 1.79B USD.
The next earnings revenue estimate has been revised upward by 9.78% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
CME revenue by date.CME revenue by date.
10.854B
50.38%		10.209B
-5.94%		11.951B
17.06%		7.163B
-40.06%		7.478B
4.40%		7.955B
6.38%		8.181B
2.84%		8.568B
4.73%
EBITDA
YoY % growth
CME ebitda by date.CME ebitda by date.
9.064B
62.52%		8.347B
-7.90%		9.991B
19.69%		5.143B
-48.52%		5.312B
3.29%		5.835B
9.85%		6.407B
9.80%		6.723B
4.93%
EBIT
YoY % growth
CME ebit by date.CME ebit by date.
8.711B
67.06%		8.011B
-8.04%		9.66B
20.59%		4.899B
-49.29%		5.139B
4.90%		5.49B
6.83%		5.968B
8.71%		6.247B
4.67%
Operating Margin
CME operating margin by date.CME operating margin by date.
80.25%78.46%80.83%68.39%68.72%69.01%72.95%72.91%
EPS
YoY % growth
CME eps by date.CME eps by date.
9.34
17.04%		10.26
9.85%		11.21
9.26%		12.28
9.56%		12.93
5.25%		13.93
7.77%		15.13
8.63%		14.70
-2.89%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		3.14
6.19%		2.99
11.58%		2.99
7.86%		3.35
-0.29%		3.31
5.42%		3.18
6.19%		3.18
6.29%		3.60
7.32%		3.56
7.28%		3.49
10.05%		3.33
4.96%
Revenue
Q2Q % growth		1.79B
5.79%		1.719B
11.80%		1.754B
6.39%		1.918B
2.02%		1.897B
5.98%		1.784B
3.78%		1.85B
5.47%		2.022B
5.42%		2B
5.43%		1.968B
10.31%		1.929B
4.27%
EBITDA
Q2Q % growth		1.301B
-53.76%		1.235B
-55.41%		1.214B
-56.97%		1.383B
-3.49%		1.36B
4.53%		1.295B
4.86%		1.278B
5.27%		1.487B
7.52%		1.459B
7.28%		1.421B
9.73%		1.356B
6.10%
EBIT
Q2Q % growth		1.264B
-52.26%		1.197B
-52.52%		1.193B
-52.09%		1.391B
-48.46%		1.353B
7.04%		1.25B
4.43%		1.26B
5.62%		1.459B
4.89%		1.432B
5.84%		1.393B
11.44%		1.328B
5.40%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CME Yearly Revenue VS EstimatesCME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
CME Yearly EPS VS EstimatesCME Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
7.51%
EPS Next 5 Year
5.56%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
6.52%
Revenue Next 5 Year
5.42%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
8.83%
EBIT Next 5 Year
8.23%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CME GROUP INC / CME Forecast FAQ

What is the average price target for CME GROUP INC (CME) stock?

20 analysts have analysed CME and the average price target is 319.66 USD. This implies a price increase of 12.14% is expected in the next year compared to the current price of 285.06.

When does CME GROUP INC (CME) report earnings?

CME GROUP INC (CME) will report earnings on 2026-07-21, before the market open.

What are the consensus estimates for CME stock next earnings?

The consensus EPS estimate for the next earnings of CME GROUP INC (CME) is 3.14 USD and the consensus revenue estimate is 1.79B USD.

Can you provide the consensus rating for CME GROUP INC stock?

The consensus rating for CME GROUP INC (CME) is 69 / 100 . This indicates that analysts generally have a neutral outlook on the stock.